Online Registration is Open!
Register by July 18 to Save up to $350 off the standard rates.
» View Pricing
Printed from the IBC Life Sciences Web site on March 7, 2014 2:48 PM ET.
Page location: http://www.ibclifesciences.com/WCB/overview.xml
November 03-04, 2014 · Washington Marriott at Metro Center · Washington, DC
Regulatory Perspective on Comparability Assessments of Biotechnology Products
Audrey Jia, M.D., Ph.D.
Division of Monoclonal Antibodies
Special Discounted Hotel Rate Available Until September 23, 2013. To book your room, call 1-800-635-5065 and mention that you are an IBC attendee at this event.
Join IBC Life Sciences' LinkedIn Group: "BioProcessing Professionals"
Follow @ibcusa on Twitter for special offers and news about the event.
Join our priority contact list and receive the latest event news.
Well Characterized Biologicals 2014
November 3-4, 2014
Washington Marriott at Metro Center
IBC's Well Characterized Biologicals conference is the leading industry conference to provide multiple, detailed case studies of the challenges, strategies and technologies involved in characterization and comparability of new biological molecules. Consistently rated as one of IBC's most in-depth and information-packed conferences, this case-study driven event also features multiple FDA speakers who present regulatory perspectives on a wide range of issues to help you with your analytical characterization efforts.
Product and Process Variants & Impurities will be covered in 2014 as part of the Well Characterized Biologicals program. Bookmark this page and check back often for conference updates. For email updates, please join our priority contact list.
"Great conference! I learned a lot and got some great ideas for the development of in-house methods. I thought the FDA presentations were terrific…and put the fear of God in me. Amazing job keeping the conference going in the face of a hurricane" - Jacqueline McGourty, Associate Director, Emergent Biosolutions
"A conference with REAL information that is readily applicable to real issues with biologicals" - Sheila Magil, Senior Consultant, Bioprocess Technology Consultants"
"Even with obstacles from Mother Nature (namely Hurricane Sandy), the conference went on and I had a wonderful experience attending" - Wing-Yee Fu, Associate Scientist, Momenta Pharmaceuticals
"Both the organizers and the presenters did an excellent job - great content, variety and relevance to today's industry needs…despite Hurricane Sandy" - James D. Mendoza, Staff Scientist, Beckman, Coulter, Inc.
"Well organized and balanced conference" - Parag Goyal, Principal Scientist, Dr. Reddy's Lab
"I enjoyed the conference. There was plenty of new knowledge gained from the presentations and new opportunities for networking with colleagues in the industry" - Bridgitte Speights, Director, CMC Regulatory Affairs, Cephalon
"This conference was very relevant with current events and trends. It provided a good arena for industry leaders to network and share ideas and best practices" - John Alvino, Manager, MedImmune
"It's a great conference in the biologics arena" - Shenjiang Yu, Associate Director, Merck & Co.
"A great conference where statistical experts and process SME's meet" - Tom Geyskens, Process Engineer, Genzyme